The Prognostic Value of Cancer Stem Cell Markers (CSCs) Expression—ALDH1A1, CD133, CD44—For Survival and Long-Term Follow-Up of Ovarian Cancer Patients

Recurrent disease and treatment-associated chemoresistance are the two main factors accounting for poor clinical outcomes of ovarian cancer (OC) patients. Both can be associated with cancer stem cells (CSCs), which contribute to cancer formation, progression, chemoresistance, and recurrence. Hence,...

Descripción completa

Detalles Bibliográficos
Autores principales: Izycka, Natalia, Rucinski, Marcin, Andrzejewska, Malgorzata, Szubert, Sebastian, Nowak-Markwitz, Ewa, Sterzynska, Karolina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916537/
https://www.ncbi.nlm.nih.gov/pubmed/36768723
http://dx.doi.org/10.3390/ijms24032400

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916537/
https://www.ncbi.nlm.nih.gov/pubmed/36768723
http://dx.doi.org/10.3390/ijms24032400

Ejemplares similares